CHMP3 — Charged Multivesicular Body Protein 3

Migration, Crosslink

📖

CHMP3 — Charged Multivesicular Body Protein 3

active

wiki page Created: 2026-04-02T07:19:29 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-chmp3

📖 Wiki Page

gene2253 wordssynced 2026-04-02

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHMP3 — Charged Multivesicular Body Protein 3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CHMP3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Charged Multivesicular Body Protein 3</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>DID2, VPS24, CHMP24</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>25973</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>609538</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000115159</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y3E0</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>222 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~24 kDa</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Neurodegeneration, lysosomal storage disorders, ALS, AD</td>
</tr>
<tr>
<td class="label">Autophagy Type</td>
<td>CHMP3 Role</td>
</tr>
<tr>
<td class="label">Macroautophagy</td>
<td>Membrane remodeling for autophagosome formation</td>
</tr>
<tr>
<td class="label">Selective autophagy</td>
<td>Recognition and clearance of protein aggregates</td>
</tr>
<tr>
<td class="label">Mitophagy</td>
<td>Mitochondrial turnover an

...

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CHMP3 — Charged Multivesicular Body Protein 3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CHMP3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Charged Multivesicular Body Protein 3</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>DID2, VPS24, CHMP24</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>25973</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>609538</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000115159</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y3E0</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>222 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~24 kDa</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Neurodegeneration, lysosomal storage disorders, ALS, AD</td>
</tr>
<tr>
<td class="label">Autophagy Type</td>
<td>CHMP3 Role</td>
</tr>
<tr>
<td class="label">Macroautophagy</td>
<td>Membrane remodeling for autophagosome formation</td>
</tr>
<tr>
<td class="label">Selective autophagy</td>
<td>Recognition and clearance of protein aggregates</td>
</tr>
<tr>
<td class="label">Mitophagy</td>
<td>Mitochondrial turnover and quality control</td>
</tr>
<tr>
<td class="label">Lysosomal fusion</td>
<td>Direct involvement in autophagosome-lysosome fusion</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain (cortex, hippocampus, substantia nigra)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Lung</td>
<td>High</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Testis</td>
<td>High</td>
</tr>
<tr>
<td class="label">Most other tissues</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">CHMP2B</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CHMP4A/B</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">VPS4B</td>
<td>ATPase regulation</td>
</tr>
<tr>
<td class="label">ALIX</td>
<td>Bridging protein</td>
</tr>
<tr>
<td class="label">Ubiquitin</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Sample</td>
</tr>
<tr>
<td class="label">CHMP3 expression</td>
<td>Brain tissue</td>
</tr>
<tr>
<td class="label">CHMP3 phosphorylation</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">Autophagic flux markers</td>
<td>Blood/CSF</td>
</tr>
<tr>
<td class="label">Lysosomal function</td>
<td>Skin fibroblasts</td>
</tr>
</table>

CHMP3 (Charged Multivesicular Body Protein 3), also known as DID2 (Doa4-independent death protein 2), is a core component of the Endosomal Sorting Complex Required for Transport-III (ESCRT-III)[@hanson2012]. This protein plays essential roles in membrane remodeling processes, including multivesicular body (MVB) formation, cytokinesis, and autophagosome-lysosome fusion. CHMP3 is highly expressed in neurons and has been increasingly recognized for its critical role in maintaining neuronal protein homeostasis[@lee2019].

The proper functioning of CHMP3 and other ESCRT-III components is essential for cellular clearance pathways that become defective in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@bauer2013]. This page provides a comprehensive overview of CHMP3's molecular function, structure, disease associations, and therapeutic implications.

Gene Overview

Molecular Structure and Function

Domain Organization

CHMP3 belongs to the CHMP (Charged Multivesicular Body Protein) family, which consists of structurally related ESCRT-III proteins[@carlson2018]. The protein contains several key structural features:

N-terminal Core Domain: Forms a helical hairpin structure that mediates polymerization and membrane interaction

Central Helical Domain: Contains the main α-helical regions responsible for protein-protein interactions

C-terminal Auto-inhibitory Helix: Functions in regulating polymerization state through intramolecular interactions

Structural Insights

Cryo-EM studies have revealed that CHMP3 adopts a helical polymeric structure when assembled into ESCRT-III filaments[@McCullough2018]. The protein can transition between:

Monomeric state: Auto-inhibited, soluble form
Polymeric state: Membrane-assembled, active form

This conformational switch is critical for its function in membrane remodeling.

ESCRT-III Complex Assembly

CHMP3 functions as a structural core of the ESCRT-III complex, which is composed of multiple charged multivesicular body proteins (CHMPs) that polymerize on endosomal membranes to drive membrane invagination and vesicle scission[@hanson2012]. The ESCRT-III complex in mammals includes several related proteins:

CHMP1A/B: Involved in late endosomal trafficking
CHMP2A/B: Critical for viral budding and MVB formation
CHMP3: Core component with essential functions
CHMP4A/B/C: Form the polymerizing filaments
CHMP5, CHMP6: Accessory components
CHMP7: Unconventional ESCRT-III with membrane remodeling activity

The assembly of ESCRT-III on endosomal membranes proceeds through a carefully orchestrated sequence:

Initiation: ESCRT-III monomers are recruited to sites of budding

Polymerization: CHMP3 and CHMP4 family members polymerize into helical filaments

Membrane constriction: The polymer contracts to drive membrane invagination

Scission: The neck is severed, releasing intralumenal vesicles

Disassembly: The complex is recycled for further rounds of budding

Membrane Remodeling Activity

CHMP3 possesses intrinsic membrane remodeling capabilities that are essential for its function. The protein contains an N-terminal microtubule-interacting and trafficking (MIT) domain-interacting (MIM) motif that allows it to engage with AAA-ATPase VPS4, which is required for disassembly of the ESCRT-III complex.

The mechanism of membrane remodeling involves:

Direct membrane binding: CHMP3 contains basic regions that associate with negatively charged phospholipids
Conformational changes: Upon polymerization, CHMP3 undergoes conformational shifts that generate membrane curvature
Cooperative assembly: CHMP3 polymerization is cooperative, allowing rapid assembly when nucleated
VPS4-mediated disassembly: The ATPase VPS4 provides the energy for disassembly, enabling recycling

Biological Functions

Multivesicular Body Formation

CHMP3 is a core component of ESCRT-III involved in the final stages of MVB formation[@agromayor2010]:

Mermaid diagram (expand to render)

Key Functions in MVB Biogenesis:

Polymerizes on endosomal membranes to drive membrane invagination
Facilitates the release of intraluminal vesicles into the MVB lumen
Works in concert with other ESCRT-III subunits (CHMP2A, CHMP2B, CHMP4A, CHMP4B, CHMP6)

Autophagy and Lysosomal Degradation

CHMP3 plays a crucial role in autophagic degradation pathways[@filimonenko2010][@rusten2012]:

Selective Autophagy: Involved in the clearance of protein aggregates and damaged organelles

Autophagosome-Lysosome Fusion: ESCRT-III components mediate the fusion of autophagosomes with lysosomes

Aggregate Clearance: Critical for removing ubiquitinated protein aggregates that accumulate in neurodegeneration

The autophagy pathway intersects with ESCRT-III function through several mechanisms:

Beyond MVB formation, CHMP3 participates in several autophagic pathways that are critical for neuronal health[@lee2019]:

Canonical Autophagy: CHMP3 contributes to the formation of autophagosomes through interactions with autophagy-related proteins. The ESCRT-III complex is recruited to nascent autophagosomes and participates in their closure and maturation.

Selective Autophagy: CHMP3 is involved in selective forms of autophagy, including:

Mitophagy: Degradation of damaged mitochondria
Lysophagy: Clearance of damaged lysosomes
ER-phagy: Turnover of endoplasmic reticulum
Aggrephagy: Clearance of protein aggregates

Endosomal-Lysosomal Pathway: CHMP3 bridges endosomal trafficking with autophagic pathways, ensuring proper delivery of cargo to lysosomes for degradation.

Cytokinesis

Beyond endosomal trafficking, CHMP3 participates in the final stages of cell division[@agromayor2010]:

Required for successful abscission during cytokinesis
Functions in the membrane fission event that separates daughter cells
Essential for cellular proliferation

Neuronal-Specific Functions

In neurons, CHMP3 has specialized functions related to the unique architecture and physiology of these cells[@metcalf2014][@sahin2015]:

Synaptic Vesicle Recycling: Involved in endosomal sorting at synaptic terminals

Axonal Transport: Participates in endosomal trafficking along axons

Neuronal Proteostasis: Critical for maintaining protein quality control in long-lived neurons

Synaptic Function: CHMP3 plays important roles at synapses, the specialized junctions where neurons communicate:

Synaptic Vesicle Trafficking: ESCRT-III components regulate the endosomal sorting of synaptic vesicle proteins
Postsynaptic Receptors: CHMP3 contributes to the trafficking and degradation of postsynaptic receptors
Synapse Maintenance: By clearing damaged proteins and organelles, CHMP3 helps maintain synaptic integrity

Axonal Transport and Integrity: Neurons depend on efficient axonal transport systems. CHMP3 contributes to axonal integrity through:

Endosomal Sorting in Axons: Essential for clearing aged proteins from distal axons
Autophagic Flux in Axons: Supports autophagic degradation in axons
Mitochondrial Quality Control: Through mitophagy, helps maintain mitochondrial health

Expression Pattern

Tissue Distribution

CHMP3 shows broad expression across multiple tissue types:

Brain Region-Specific Expression

Within the brain, CHMP3 is expressed in:

Cortex: Particularly in pyramidal neurons
Hippocampus: High expression in CA1 and CA3 regions
Substantia nigra: Dopaminergic neurons
Cerebellum: Purkinje cells
Spinal cord: Motor neurons

Cellular Localization

CHMP3 localizes to:

Cytosol: Soluble pool in dynamic equilibrium with membrane-bound pool
Endosomes: Associated with limiting membranes
Autophagosomes: During active autophagy
Plasma membrane: Transient recruitment during cytokinesis

Role in Neurodegeneration

Alzheimer's Disease

CHMP3 dysfunction contributes to AD pathogenesis through multiple mechanisms[@cheng2021]:

Amyloid Processing: Impaired endosomal trafficking affects amyloid precursor protein (APP) processing and Aβ production

Tau Pathology: Disrupted autophagy leads to accumulation of hyperphosphorylated tau

Lysosomal Dysfunction: ESCRT-III impairment contributes to lysosomal membrane permeabilization

Neuronal Vulnerability: Accumulation of undigested materials leads to neuronal death

Key Evidence:

Post-mortem AD brains show altered CHMP3 distribution in neurons
ESCRT-III components co-localize with amyloid plaques and neurofibrillary tangles
Genetic variants in ESCRT-related genes are associated with AD risk

Parkinson's Disease

CHMP3 plays important roles in PD pathogenesis[@liu2024]:

Alpha-Synuclein Clearance: Impaired selective autophagy leads to α-synuclein accumulation

Mitochondrial Quality Control: ESCRT-III dysfunction affects mitophagy

Dopaminergic Neuron Survival: Enhanced vulnerability due to autophagic impairment

Key Evidence:

CHMP3 expression is altered in PD patient brain tissue
ESCRT-III dysfunction exacerbates α-synuclein toxicity in models
Mutations in ESCRT-related genes are linked to familial PD

Amyotrophic Lateral Sclerosis

CHMP3 and other ESCRT-III components are implicated in ALS[@bauer2013]:

Stress Granule Dynamics: ESCRT-III is involved in stress granule assembly/disassembly

TDP-43 Pathology: Impaired autophagy contributes to TDP-43 aggregation

Axonal Transport: Endosomal dysfunction affects axonal maintenance

Other Neurodegenerative Conditions

Huntington's Disease: Altered ESCRT-III function in polyglutamine toxicity
Frontotemporal Dementia: Implicated in tau and TDP-43 pathology
Lysosomal Storage Disorders: Primary dysfunction of lysosomal pathway

Mechanisms of Neurodegeneration

The following pathways link CHMP3 dysfunction to neuronal death:

Mermaid diagram (expand to render)

Protein Interactions

CHMP3 interacts with several key proteins relevant to neurodegeneration:

Therapeutic Implications

Therapeutic Strategies

Targeting CHMP3 and ESCRT-III function represents a promising therapeutic approach[@chen2022]:

Small Molecule Enhancers: Compounds that promote ESCRT-III assembly or function

Gene Therapy: Viral delivery of functional CHMP3

Protein Replacement: Delivery of functional ESCRT-III components

Autophagy Enhancement: Upstream activation of autophagy pathways

Modulating CHMP3 and ESCRT-III function represents a therapeutic approach:

Enhancing Autophagic Flux: Pharmacological approaches:

mTOR inhibitors: Rapamycin and analogs promote autophagy
ESCRT activators: Small molecules that enhance ESCRT assembly
VPS4 modulators: Compounds affecting VPS4 activity

Challenges and Considerations

Cell-Type Specificity: Targeting neurons specifically in the brain
Balance of Function: ESCRT-III has both pro-survival and pro-death roles
Delivery: Crossing the blood-brain barrier

Biomarker Potential

CHMP3 and related ESCRT-III components may serve as[@cheng2021][@wilson2023]:

Diagnostic Markers: Peripheral blood or CSF measurement
Progression Markers: Correlation with disease severity
Therapeutic Targets: Direct modulation of ESCRT function

[CHMP2B](/genes/chmp2b) - Related ESCRT-III component
[CHMP4A](/genes/chmp4a) - ESCRT-III member
[VPS4B](/genes/vps4b) - ATPase regulating ESCRT-III

[ESCRT Pathway](/mechanisms/esCRT-pathway) - Mechanism page
[Autophagy](/mechanisms/autophagy) - Core mechanism
[Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction) - Related mechanism
[Protein Quality Control](/mechanisms/protein-quality-control-network) - Quality control

[Alzheimer's Disease](/diseases/alzheimers-disease) - AD page
[Parkinson's Disease](/diseases/parkinsons-disease) - PD page
[ALS](/diseases/amyotrophic-lateral-sclerosis) - ALS page

External Links

[NCBI Gene: CHMP3](https://www.ncbi.nlm.nih.gov/gene/25973)
[UniProt: Q9Y3E0](https://www.uniprot.org/uniprot/Q9Y3E0)
[Ensembl: CHMP3](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000115159)
[OMIM: 609538](https://www.omim.org/entry/609538)

References

[Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annual Review of Cell and Developmental Biology. 2012.](https://pubmed.ncbi.nlm.nih.gov/22831642/)

[Lee JA, Liu L, Gao FB. Autophagy defects in neurodegenerative diseases. Aging Cell. 2019.](https://pubmed.ncbi.nlm.nih.gov/31222865/)

[Agromayor M, et al. The ESCRT-III component CHMP3 is required for cytokinesis and cell-cell adhesion. PLoS ONE. 2010.](https://pubmed.ncbi.nlm.nih.gov/20862251/)

[Carlson LA, et al. Cryo-EM of the human ESCRT-III complex. Proceedings of the National Academy of Sciences. 2018.](https://pubmed.ncbi.nlm.nih.gov/30266760/)

[McCullough J, et al. Structure and function of the ESCRT-III complex. Nature Reviews Molecular Cell Biology. 2018.](https://pubmed.ncbi.nlm.nih.gov/29976797/)

[Bauer I, et al. CHMP3 mutations in neurodegenerative disease. Human Molecular Genetics. 2013.](https://pubmed.ncbi.nlm.nih.gov/23677655/)

[Filimonenko M, et al. The selective macroautophagy of pathogens and aggregates. Journal of Cell Biology. 2010.](https://pubmed.ncbi.nlm.nih.gov/20620997/)

[Rusten TE, et al. ESCRT and autophagy's intertwined roles in membrane dynamics. Trends in Cell Biology. 2012.](https://pubmed.ncbi.nlm.nih.gov/22464748/)

[Metcalf D, et al. ESCRT-III dysfunction in neurodegeneration. Journal of Neuroscience. 2014.](https://pubmed.ncbi.nlm.nih.gov/25186741/)

[Sahin E, et al. CHMP3 and endosomal trafficking in neuronal cells. Molecular Biology of the Cell. 2015.](https://pubmed.ncbi.nlm.nih.gov/25851604/)

[Feng X, et al. ESCRT-III subunit CHMP3 in autophagic clearance of protein aggregates. Autophagy. 2020.](https://pubmed.ncbi.nlm.nih.gov/32396614/)

[Cheng L, et al. CHMP3 and lysosomal dysfunction in Alzheimer's disease. Acta Neuropathologica Communications. 2021.](https://pubmed.ncbi.nlm.nih.gov/33494761/)

[Chen X, et al. Targeting ESCRT-III for neurodegenerative disease therapy. Nature Reviews Drug Discovery. 2022.](https://pubmed.ncbi.nlm.nih.gov/35102292/)

[Wilson S, et al. Endosomal sorting and autophagy in neurons. Trends in Neurosciences. 2023.](https://pubmed.ncbi.nlm.nih.gov/36891023/)

[Liu Y, et al. ESCRT-III dysfunction in Parkinson's disease models. Cell Reports. 2024.](https://pubmed.ncbi.nlm.nih.gov/38289876/)

[McAlear TS, et al. ESCRT-III mediated lysosomal repair in neurodegenerative disease. Autophagy. 2019.](https://pubmed.ncbi.nlm.nih.gov/31026945/)

[Hanzel J, et al. Targeting ESCRT-III components for therapeutic intervention. Journal of Medicinal Chemistry. 2021.](https://pubmed.ncbi.nlm.nih.gov/33605891/)

[Botta L, et al. CHMP2B and CHMP3 in frontotemporal dementia and ALS. Acta Neuropathologica Communications. 2022.](https://pubmed.ncbi.nlm.nih.gov/35614437/)

[Urwin H, et al. CHMP2B mutations in ALS and FTD. Brain. 2020.](https://pubmed.ncbi.nlm.nih.gov/32814957/)

[Yang Y, et al. ESCRT-mediated membrane repair in neurons. Cell Reports. 2023.](https://pubmed.ncbi.nlm.nih.gov/37827018/)

[Alabi RO, et al. ESCRT biology in neurodegenerative disease. Nature Reviews Neuroscience. 2022.](https://pubmed.ncbi.nlm.nih.gov/36376561/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CHMP3 — Charged Multivesicular Body Protein 3 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CHMP3

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-chmp3
kg_node_id	CHMP3
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-31d38347bb82
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-chmp3'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

23

Outgoing

28

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CHMP3 — Charged Multivesicular Body Protein 3

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

Gene Overview

Molecular Structure and Function

Domain Organization

Structural Insights

ESCRT-III Complex Assembly

Membrane Remodeling Activity

Biological Functions

Multivesicular Body Formation

Autophagy and Lysosomal Degradation

Cytokinesis

Neuronal-Specific Functions

Expression Pattern

Tissue Distribution

Brain Region-Specific Expression

Cellular Localization

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Mechanisms of Neurodegeneration

Protein Interactions

Therapeutic Implications

Therapeutic Strategies

Challenges and Considerations

Biomarker Potential

See Also

External Links

References

Pathway Diagram

💬 Discussion

📗 Cite This Artifact

CHMP3 — Charged Multivesicular Body Protein 3

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

CHMP3 — Charged Multivesicular Body Protein 3

Introduction

Gene Overview

Molecular Structure and Function

Domain Organization

Structural Insights

ESCRT-III Complex Assembly

Membrane Remodeling Activity

Biological Functions

Multivesicular Body Formation

Autophagy and Lysosomal Degradation

Cytokinesis

Neuronal-Specific Functions

Expression Pattern

Tissue Distribution

Brain Region-Specific Expression

Cellular Localization

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Mechanisms of Neurodegeneration

Protein Interactions

Therapeutic Implications

Therapeutic Strategies

Challenges and Considerations

Biomarker Potential

Cross-Links to Related Topics

Related Genes and Proteins

Related Mechanisms

Related Diseases

See Also

External Links

References

Pathway Diagram

💬 Discussion